Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790))

Joseph Stauffer; Beatrice Setnik; Marta Sokolowska

doi:10.2165/11533600-000000000-00000

Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790))

Joseph Stauffer, Beatrice Setnik, Marta Sokolowska

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	598
Number of pages	1
Journal	Clinical Drug Investigation
Volume	31
Issue number	8
DOIs	https://doi.org/10.2165/11533600-000000000-00000
State	Published - 2011
Externally published	Yes

Keywords

Controlled-release-drugs
Errata
Morphine
Morphinenaltrexone
Opioid-abuse
Opioid-analgesics
Pain
Research-and-development

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.2165/11533600-000000000-00000

Cite this

Stauffer, J., Setnik, B., & Sokolowska, M. (2011). Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790)). Clinical Drug Investigation, 31(8), 598. https://doi.org/10.2165/11533600-000000000-00000

Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790)). / Stauffer, Joseph; Setnik, Beatrice; Sokolowska, Marta.
In: Clinical Drug Investigation, Vol. 31, No. 8, 2011, p. 598.

Research output: Contribution to journal › Comment/debate › peer-review

Stauffer, J, Setnik, B & Sokolowska, M 2011, 'Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790))', Clinical Drug Investigation, vol. 31, no. 8, pp. 598. https://doi.org/10.2165/11533600-000000000-00000

Stauffer J, Setnik B, Sokolowska M. Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790)). Clinical Drug Investigation. 2011;31(8):598. doi: 10.2165/11533600-000000000-00000

Stauffer, Joseph ; Setnik, Beatrice ; Sokolowska, Marta. / Erratum : Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790)). In: Clinical Drug Investigation. 2011 ; Vol. 31, No. 8. pp. 598.

@article{43a2f6bba4d345fe8f4de264ae73ee86,

title = "Erratum: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790))",

keywords = "Controlled-release-drugs, Errata, Morphine, Morphinenaltrexone, Opioid-abuse, Opioid-analgesics, Pain, Research-and-development",

author = "Joseph Stauffer and Beatrice Setnik and Marta Sokolowska",

year = "2011",

doi = "10.2165/11533600-000000000-00000",

language = "English (US)",

volume = "31",

pages = "598",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis International Ltd",

number = "8",

}

TY - JOUR

T1 - Erratum

T2 - Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: A randomized, doubleblind, placebo-controlled, crossover study (Clinical Drug Investigation (2009) 29:12 (777-790))

AU - Stauffer, Joseph

AU - Setnik, Beatrice

AU - Sokolowska, Marta

PY - 2011

Y1 - 2011

KW - Controlled-release-drugs

KW - Errata

KW - Morphine

KW - Morphinenaltrexone

KW - Opioid-abuse

KW - Opioid-analgesics

KW - Pain

KW - Research-and-development

UR - http://www.scopus.com/inward/record.url?scp=79960013064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960013064&partnerID=8YFLogxK

U2 - 10.2165/11533600-000000000-00000

DO - 10.2165/11533600-000000000-00000

M3 - Comment/debate

AN - SCOPUS:79960013064

SN - 1173-2563

VL - 31

SP - 598

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 8

ER -

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this